Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ami Patel

Showing results (171-180 of 209) with videos related to

Pageof 21
Sort By:
MMWR. Morbidity and Mortality Weekly Report|April 29, 2021
Linked Clusters of SARS-CoV-2 Variant B.1.351 - Maryland, January-February 2021Kenneth A Feder, Marcia Pearlowitz, Alexandra Goode, et al.
Nature Medicine|October 21, 2025
Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 trialPablo Tebas, Ami Patel, Joseph T Agnes, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2026
Nanoparticle Immunoadjuvant Complexes Augment Germinal Center Responses to VaccinationNicholas J Tursi, Colby J Agostino, Jinwei Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2014
Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012Anil G Suryaprasad, Jianglan Z White, Fujie Xu, et al.
Frontiers in Immunology|August 18, 2025
Fc-modification of anti-PcrV gene-encoded antibodies modulates complement-mediated killing of Pseudomonas aeruginosaJillian Eisenhauer, Spencer Dublin, Jihae Choi, et al.
NPJ Vaccines|December 22, 2017
DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infectionsSarah T C Elliott, Nicole L Kallewaard, Ebony Benjamin, et al.
The Journal of Infectious Diseases|March 21, 2019
Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy VolunteersPablo Tebas, Kimberly A Kraynyak, Ami Patel, et al.
Cancer|November 27, 2023
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancerEmily M Hinchcliff, Anne Knisely, Naomi Adjei, et al.
American Journal of Hematology|October 18, 2018
A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agentsNicholas J Short, Elias Jabbour, Kiran Naqvi, et al.
JCI Insight|April 22, 2021
Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirusAmi Patel, Emma L Reuschel, Ziyang Xu, et al.
Pageof 21

Showing results (171-180 of 209) with videos related to

Sort By:
Pageof 21
MMWR. Morbidity and Mortality Weekly Report|April 29, 2021
Linked Clusters of SARS-CoV-2 Variant B.1.351 - Maryland, January-February 2021Kenneth A Feder, Marcia Pearlowitz, Alexandra Goode, et al.
Nature Medicine|October 21, 2025
Safety and pharmacokinetics of SARS-CoV-2 DNA-encoded monoclonal antibodies in healthy adults: a phase 1 trialPablo Tebas, Ami Patel, Joseph T Agnes, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 28, 2026
Nanoparticle Immunoadjuvant Complexes Augment Germinal Center Responses to VaccinationNicholas J Tursi, Colby J Agostino, Jinwei Huang, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2014
Emerging epidemic of hepatitis C virus infections among young nonurban persons who inject drugs in the United States, 2006-2012Anil G Suryaprasad, Jianglan Z White, Fujie Xu, et al.
Frontiers in Immunology|August 18, 2025
Fc-modification of anti-PcrV gene-encoded antibodies modulates complement-mediated killing of Pseudomonas aeruginosaJillian Eisenhauer, Spencer Dublin, Jihae Choi, et al.
NPJ Vaccines|December 22, 2017
DMAb inoculation of synthetic cross reactive antibodies protects against lethal influenza A and B infectionsSarah T C Elliott, Nicole L Kallewaard, Ebony Benjamin, et al.
The Journal of Infectious Diseases|March 21, 2019
Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy VolunteersPablo Tebas, Kimberly A Kraynyak, Ami Patel, et al.
Cancer|November 27, 2023
Randomized phase 2 trial of tremelimumab and durvalumab in combination versus sequentially in recurrent platinum-resistant ovarian cancerEmily M Hinchcliff, Anne Knisely, Naomi Adjei, et al.
American Journal of Hematology|October 18, 2018
A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agentsNicholas J Short, Elias Jabbour, Kiran Naqvi, et al.
JCI Insight|April 22, 2021
Intradermal delivery of a synthetic DNA vaccine protects macaques from Middle East respiratory syndrome coronavirusAmi Patel, Emma L Reuschel, Ziyang Xu, et al.
Pageof 21